Abstract
Objective: To determine the effective nucleotide sites of ribozymes against HCV, and obtain a highly effective, nontoxic and inexpensive antisense ribozyme specific for HCV. Methods: Two effective ribozymes, targeted to HCV 5’NC region and C region, were designed and synthesized. Eukaryotic expression vectors, pSV2-gpt. CD-SR (, containing either HCRZNC or HCRZC were constructued and transfected into MT-2 cells, which had been infected by HCV. Quantitative PCR and hydridization were used to determine the effect of inhibition of HCV by ribozymes. Results: HCRZNC and HCRZC suppressed the replication of HCV by 54.7% and 62.1%, respectively. Furthermore, when both ribozymes were cotransfected into cells, they suppressed replication by 78.8%. Conclusion: Two specific antisense ribozymes have strong inhibitory effects on the replication of HCV in cultured cells, and have better effect when used together.
This is a preview of subscription content, log in via an institution to check access.
References
Chen, Z., Dennin R. H., He, N. X. et al., 1995. Detection of minus strand RNA of HCV in liver tissues of patient with hepatitis C and hepatocellular carcinoma by RT-PCR.Chinese J. of Microbiology and Immunology,15(2): 116–118 (in Chinese, with English abstract).
Hagiwara, H., Hangashi, N., Mitta, E. et al., 1993. Quantitative analysis of hepatitis C virus RNA in serum during interferon therapy.Gaseroenterology,104: 877.
Haseloff, J., Gerlach, W. L., 1988. Simple RNA enzymes with new and highly specific endoribonuclease activities.Nature. 18,334(6183):585.
Kasahara, A., Hagiwara, H., Hayasi, N. et al., 1995. Ability of prolonged interferon treatment to suppress ralapse after cessation of therapy in patients with chronic hepatitis C a multicenter randomized controlled trial.Hepatology,21:291–297.
Kruger, K., Grabowski, P. J., Zaug A. J. et al., 1982. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena.Cell.31(1):147.
Mitta, E., Hayashi, N., Hagiwara H et al., 1994. predicting interferon therapy efficacy from hepatitis C virus genometype and RNA titer.Dig. Dis Sci;39:977.
Ohkawa, J., Koguma, T., Kohda, T. et al., 1995. Ribozymes: from mechanistic studies to applications in vivo.J Biochem (Tokyo),118(2):251.
Sakamoto, N., Wu, C. H., Wu, G. Y., 1996. Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes.J Clin Invest.98(12):2720.
Sarver, N., Cantin, E. M., Chang P. S. et al., 1990. Ribozymes as potential anti-HIV-1 therapeutic agents.Science,247(4947):1222.
Weizsacker I. F., Blum H. E., Wards G. R., 1992. Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template.Biochem Biophys Res Commun.189:243.
Welch, P. J., Tritz, R., Yei, S. et al., 1996. A Polential therapeutic application of hairpin ribozymes:in vitro andin vivo studies of gene therapy for hapatitis C virus infeetion.Gene ther.3(11):994–1001.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhi, C., Yong, L., Ke-zhou, L. et al. In vitro study on ribozyme against hepatitis C virus. J. Zheijang Univ.-Sci. 2, 100–103 (2001). https://doi.org/10.1631/BF02841185
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/BF02841185